These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Sample size determination and statistical power in randomized controlled trials. Sjögren P; Hedström L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528 [No Abstract] [Full Text] [Related]
49. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods. Graves N; Walker D; Raine R; Hutchings A; Roberts JA Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373 [TBL] [Abstract][Full Text] [Related]
50. Improving the quality of reporting in randomised controlled trials. Walker A; Nixon J J Wound Care; 2004 Mar; 13(3):103-6. PubMed ID: 15045804 [No Abstract] [Full Text] [Related]
51. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level. Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796 [TBL] [Abstract][Full Text] [Related]
53. Randomized two-stage Phase II clinical trial designs based on Barnard's exact test. Shan G; Ma C; Hutson AD; Wilding GE J Biopharm Stat; 2013; 23(5):1081-90. PubMed ID: 23957517 [TBL] [Abstract][Full Text] [Related]
54. Assessing quality of reports on randomized clinical trials in nursing journals. Parent N; Hanley JA Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902 [TBL] [Abstract][Full Text] [Related]
55. On model selections for repeated measurement data in clinical studies. Zou B; Jin B; Koch GG; Zhou H; Borst SE; Menon S; Shuster JJ Stat Med; 2015 May; 34(10):1621-33. PubMed ID: 25645442 [TBL] [Abstract][Full Text] [Related]
56. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure. Trafimow D; Rice S Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377 [No Abstract] [Full Text] [Related]
57. Bayesian Analysis: A Practical Approach to Interpret Clinical Trials and Create Clinical Practice Guidelines. Bittl JA; He Y Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28798016 [TBL] [Abstract][Full Text] [Related]
58. Designing randomised trials: both large and small trials are needed. Stenning SP; Parmar MK Ann Oncol; 2002; 13 Suppl 4():131-8. PubMed ID: 12401679 [No Abstract] [Full Text] [Related]
59. Confirmatory clinical trials with an adaptive design. Koch A Biom J; 2006 Aug; 48(4):574-85. PubMed ID: 16972708 [TBL] [Abstract][Full Text] [Related]
60. Can we inflate effect size and thus increase chances of producing "positive" results if we raise the baseline threshold in schizophrenia trials? Furukawa TA; Leucht S Schizophr Res; 2013 Mar; 144(1-3):105-8. PubMed ID: 23312551 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]